New Research Links Higher B Vitamin Levels with Lower Stroke Risk

Why It Matters

Stroke is the leading cause of disability in the U.S.; even modest risk reductions through affordable dietary changes can have sizable public‑health impact.

Key Takeaways

• 222,000 participants studied across two large U.S. cohorts.
• High B1‑B3, B6, folate intake reduces stroke risk ~20%.
• Folate benefit rises up to 2,000 dietary folate equivalents daily.
• Non‑folate B vitamins show reverse J‑shaped risk curve.
• Food sources preferred; supplements only for specific deficiencies.

Pulse Analysis

Stroke remains the leading cause of long‑term disability in the United States, accounting for roughly 795,000 hospitalizations each year. While traditional risk factors such as hypertension, smoking, and sedentary lifestyle dominate prevention guidelines, nutrition is gaining attention as a modifiable element. A recent analysis published in the American Journal of Preventive Cardiology pooled data from the Women’s Health Initiative and the All of Us Research Program, encompassing about 222,000 adults followed for up to two decades. The investigators found that participants with the highest dietary intake of several B‑complex vitamins experienced up to a 20 percent lower incidence of ischemic or hemorrhagic stroke compared with those at the bottom of the intake distribution.

The protective signal appears to be driven by multiple biochemical pathways. Elevated B‑vitamin status, particularly folate, reduces plasma homocysteine—a sulfur‑containing amino acid that promotes endothelial dysfunction and thrombosis. In the cohort, homocysteine mediated roughly 11 percent of folate’s effect, suggesting additional mechanisms. Several B vitamins also modulate systemic inflammation and support mitochondrial energy production, both critical for vascular health. Notably, the dose‑response was not uniform: folate showed a linear benefit up to about 2,000 dietary folate equivalents per day, whereas thiamin, riboflavin, niacin and pyridoxine exhibited a reverse‑J curve, indicating potential diminishing returns beyond a personal threshold.

For clinicians and policymakers, the findings reinforce existing dietary recommendations that emphasize whole grains, leafy greens, legumes, and lean animal proteins as natural sources of the B‑complex. Supplementation may be justified for individuals with documented deficiencies, elevated homocysteine, or high cardiovascular risk, but the evidence does not support indiscriminate high‑dose regimens. Public‑health campaigns could leverage this data to promote affordable, food‑based strategies that simultaneously address fiber, micronutrient, and antioxidant intake. Future randomized trials are needed to confirm causality and to define optimal intake ranges for each B vitamin in stroke prevention.